Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1741
-
1742
-
1743
-
1744
-
1745
Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.
Published 2025“…<p>Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.…”
-
1746
-
1747
-
1748
Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils.
Published 2013“…C and D: blocking CD88 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. …”
-
1749
Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress
Published 2016“…Here we demonstrate that the HCC cells with a poor prognostic hepatic stem cell subtype (Subtype HS) are more resistant to heat stress than HCC cells with a better prognostic hepatocyte subtype (Subtype HC). …”
-
1750
GSK360A increased kidney EPO and brain VEGF mRNA after stroke.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1751
Effect of GSK360A on APA learning performance 3 weeks after tMCAO stroke.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1752
The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1753
Body weight was measured over the course of the study.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1754
Hypoxia-inducible factors (HIFs) are transcription factors that respond to changes in environmental oxygen.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1755
TTC staining of forebrain 2 mm thick sections conducted 4 weeks after tMCAO stroke (1 week after APA testing).
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1756
Overall schematic of basic experimental studies and designs.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1757
The chemical structure and the enzymatic and cellular activity of GSK360A.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1758
-
1759
LM11A-31 reverses dystrophy of cholinergic neurites that occurs with aging in APP<sup>L/S</sup> mice.
Published 2014“…<p>Quantitative analysis of the effect of aging showed that 13â14 month old vehicle-treated APP<sup>L/S</sup> (APP) mice had ChAT neurites in basal forebrain with decreased (<b><i>A</i></b>) length and (<b><i>B</i></b>) area and had dystrophic neurite clusters in cortex that occupied more area (<b><i>C</i></b>) and were larger (<b><i>D</i></b>) compared to the 9â11 month old APP Veh mice. …”
-
1760